In a number of neurodegenerative diseases, a change in the conformatio
n of specific proteins occurs which is considered to be related to the
development of the disease process. In general, a change in the prote
in conformation from a predominantly alpha-helical to a predominantly
beta-sheet structure, due to genetic or environmental factors, leads t
o oligomerization of the proteins. In Alzheimer's and prion diseases,
insoluble precipitates or plaques are often observed in vivo as a cons
equence of beta-fibril formation due to the polymerization of the prot
eins. In certain other neurodegenerative diseases, for example in Hunt
ington disease, the beta-sheet oligomers may interact differently with
other functional proteins compared to the monomeric proteins inducing
the disease. Biophysical studies would provide information regarding
the forces responsible for the oligomerization of these proteins and h
ence provide methods for detecting these diseases, leading eventually
to therapeutic approaches.